首页> 外国专利> Participation of The Pathway of androgen / androgen receptors in Fabry disease

Participation of The Pathway of androgen / androgen receptors in Fabry disease

机译:雄激素/雄激素受体通路参与法布里病

摘要

Treatments for Fabry's disease include the use of molecules related to the androgenes / androgenes (AR) carrier (AR) as biologists, and the use of methods related to the androgenes / AR carrier (AR). Before. This document describes (I) the use of androgenes / AR in the treatment of Fabry's disease, and (II) the use of molecular levels in human fluids or tissues related to the androgenes / AR pathway as biologists to assessThis is Dr Vance's disease and the effectiveness of the treatment of patients with Fabry One way to diagnose Fabry's disease involves taking samples from people suspected of having itIn a sample of subjects suspected of Fabry's disease, the levels of one or more selected component molecules were compared, including an androgeno, a precursor of androgeno, a metabolite of androgeno, a molecule of androgenos (AR) receptor, and one or more related ar genes and metabolites, According to the situation of a normal person (he did not suffer from Fabry's disease) and the statistically significant change in the content of one or more molecules in the sample between the person suspected of suffering from Fabry's disease and the normal person, determine whether he has Fabry's disease.
机译:法布里氏病的治疗方法包括使用与雄激素/雄激素(AR)载体有关的分子作为生物学家,以及与雄激素/ AR载体有关的方法。之前。本文档描述了(I)雄激素/ AR在治疗法布里氏病中的用途,以及(II)分子水平在与雄激素/ AR途径有关的人类体液或组织中的生物学家作为生物学家评估这是万斯博士的疾病和法布里病患者治疗的有效性诊断法布里病的一种方法是从怀疑患有法布里病的人中取样在怀疑患有法布里病的受试者的样本中,比较了一个或多个选定成分分子的水平,包括雄激素,前体雄激素(雄激素的代谢物,雄激素受体分子)以及一个或多个相关的ar基因和代谢物的含量,根据正常人(他未患有法布里氏病)的情况以及怀疑患有法布里氏病的人与正常人之间样品中一种或多种分子的含量,确定他是否患有法布里氏病。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号